Management of Primary Pulmonary Hypertension

作者: Milton Packer

DOI: 10.1007/978-1-4613-1773-9_10

关键词: MedicinePulmonary arteryOpen lung biopsyPulmonary hypertensionLungSurgeryInternal medicineVascular resistanceSmall specimenDiseaseWorld health

摘要: Primary pulmonary hypertension represents a heterogenous group of disorders in which artery pressure and vascular resistance are markedly elevated the absence known causes {1–3}. Although disease commonly afflicts young women, patients any sex or age may be affected. Three distinct pathologic subtypes primary pumonary hyper­tension recognized by World Health Organization {4}: plexogenic arteriopathy, microthromboembolism, veno­occlusive disease, but it remains unknown whether these categories represent eti­ologies with common final clinical picture different manifestations same disease. The dilemma is made more complicated fact that can­not distinguished clinically confidence, attempts to establish diagnosis open lung biopsy risks possibility changes seen small specimen not present throughout {5}.

参考文章(109)
Stuart Rich, Jorge Martinez, Wilfred Lam, Paul S. Levy, Kenneth M. Rosen, Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: Guidelines for determining a pulmonary vasodilator response American Heart Journal. ,vol. 105, pp. 119- 127 ,(1983) , 10.1016/0002-8703(83)90288-0
R. Ross, J. Glomset, B. Kariya, L. Harker, A Platelet-Dependent Serum Factor That Stimulates the Proliferation of Arterial Smooth Muscle Cells In Vitro Proceedings of the National Academy of Sciences of the United States of America. ,vol. 71, pp. 1207- 1210 ,(1974) , 10.1073/PNAS.71.4.1207
B. Astedt, S. Isacson, I. M. Nilsson, M. Pandolfi, Thrombosis and oral contraceptives: possible predisposition. BMJ. ,vol. 4, pp. 631- 634 ,(1973) , 10.1136/BMJ.4.5893.631
T.David Lee, George C. Roveti, Richard S. Ross, The hemodynamic effects of isoproterenol on pulmonary hypertension in man American Heart Journal. ,vol. 65, pp. 361- 367 ,(1963) , 10.1016/0002-8703(63)90011-5
I F McMurtry, A B Davidson, J T Reeves, R F Grover, Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circulation Research. ,vol. 38, pp. 99- 104 ,(1976) , 10.1161/01.RES.38.2.99
S W Wang, J E Pohl, D J Rowlands, E G Wade, Diazoxide in treatment of primary pulmonary hypertension. Heart. ,vol. 40, pp. 572- 574 ,(1978) , 10.1136/HRT.40.5.572
H Ikram, A H Maslowski, M G Nicholls, E A Espiner, F T Hull, Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension. Heart. ,vol. 48, pp. 541- 545 ,(1982) , 10.1136/HRT.48.6.541
George Walcott, Howard B. Burchell, Arnold L. Brown, Primary pulmonary hypertension The American Journal of Medicine. ,vol. 49, pp. 70- 79 ,(1970) , 10.1016/S0002-9343(70)80115-2
D. R. Dantzker, J. S. Bower, Pulmonary vascular tone improves VA/Q matching in obliterative pulmonary hypertension Journal of Applied Physiology. ,vol. 51, pp. 607- 613 ,(1981) , 10.1152/JAPPL.1981.51.3.607
M B Kahaleh, G K Sherer, E C LeRoy, ENDOTHELIAL INJURY IN SCLERODERMA Journal of Experimental Medicine. ,vol. 149, pp. 1326- 1335 ,(1979) , 10.1084/JEM.149.6.1326